Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mimi C Tan, MD, MPH
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital de Cancer de Barretos - Fundacao Pio Xii
Barretos, São Paulo, Brazil
Claudio Hashimoto, MD, MBAElisa R Baba, MD, PhDRecruiting - Instituto Do Câncer Do Estado de São Paulo
São Paulo, São Paulo, Brazil
Evandro Sobroza de Mello, MDFauze Maluf-Filho, MDRecruiting
- Baylor St. Luke'S Medical Center
Houston, Texas, United States
Mimi C Tan, MD, MPHRecruiting - Ben Taub Hospital (harris Health Systems)
Houston, Texas, United States
Mimi C Tan, MD, MPHRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Feb 2025
- Primary completion
- 1 Mar 2027
- Completion
- 1 Mar 2027
- Last update posted
- 2 Mar 2026
- Registered enrollment
- 200
- Registry id
- NCT06435286
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.